tbuckley/cabot-search huggingface dataset:
Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag - Results of the 5th Interim Analysis of the Study RISA, with Special Consideration of Treatment Discontinuations
Authors: Oliver Meyer, Rudolf Schlag, Thomas Stauch, Bastian Fleischmann, Marcel Reiser, Dietrich Kaempfe, Timo Behlendorf, Manfred Welslau, Eyck von der Heyde, Steffen Dörfel, Claudia Willy, Martina Stauch
Journal: Blood (2022)
Estimation of Long-Term Post-Infusion Costs of Care for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Following Administration of Idecabtagene Vicleucel (ide-cel, bb2121) in the KarMMa Clinical Trial
Authors: November McGarvey, Thomas Carattini, Brian Ung, Timothy B. Campbell, Ken Imanak, Pallavi Patwardhan
Journal: Blood (2022)
Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone with Carfilzomib in Relapsed or Refractory Multiple Myeloma. Iskpd - IFM2018-03
Authors: Arthur Bobin, Jerome Lambert, Stéphanie Ragot, Aurore Perrot, Salomon Manier, Lionel Karlin, Denis Caillot, Cyrille Hulin, Lotfi Benboubker, Carla Araujo, Jean Fontan, Thorsten Braun, Clara Mariette, Elodie Scherman, Olivier Decaux, jean Sebastien Blade, Faida Keddar, Christophe Roul, Mamoun Dib, Jill Corre, Frederique Orsini, Laure Vincent, Mohamad Mohty, Cyrille Touzeau, Philippe Moreau, Herve Avet Loiseau, Xavier Leleu
Journal: Blood (2022)
Healthcare Utilization Among Patients with Advanced Systemic Light Chain Amyloidosis
Authors: Morie A. Gertz, Rafat Abonour, Sarah N. Gibbs, Muriel Finkel, Heather Landau, Suzanne Lentzsch, Grace Lin, Anuj Mahindra, Tiffany P. Quock, Cara A. Rosenbaum, Michael Rosenzweig, Surbhi Sidana, Sascha A. Tuchman, Ronald Witteles, Irina Yermilov, Michael S. Broder
Journal: Blood (2022)
Targeting Cholesterol Homeostasis Pathway to Overcome Acquired Cytarabine Resistance in Acute Myeloid Leukemia
Authors: Saswati Das, Raveen Stephen Stallon Illangeswaran, Daniel Zechariah Paul Zechariah Paul Jebanesan, Rakhi Thalayatta Vidhyadharan, Vikram Mathews, Shaji Ramachandran Velayudhan, Poonkuzhali Balasubramanian
Journal: Blood (2022)
Impact on Survival of the Introduction of New Therapies for Relapsed-Refractory Aggressive B-Cell Lymphoma, Based on the Relinf Registry: A Study By the Spanish Geltamo Group
Authors: Mariana Bastos-Oreiro, Ana Jimenez-Ubieto, Sonia González de Villambrosia, Raul Cordoba, Elena Pérez Ceballos, EVA Maria DONATO Martin, Ana Muntañola Prat, Hugo Daniel Luzardo Henriquez, Lourdes Escoda, Maria Jesús Peñarrubia, María Pozas, Alberto Lopez-Garcia, Daniel Garcia, Emilia Pardal, Claudia Salazar Lozada, Alejandro Martín García-Sancho
Journal: Blood (2022)
PLX-R18 (Avoplacel), a Placental Expanded Mesenchymal-like Stromal Cell Therapy Shows Favorable Safety and Appears to Improve Incomplete Hematopoietic Recovery after Hematopoietic Cell Transplantation (HCT)
Authors: Hillard M Lazarus, Joseph P. McGuirk, Tsila Zuckerman, Leland Metheny, Luis Pineiro, Mark R. Litzow, Scott D. Rowley, Batia Avni, Roni Tamari, Michal Sheleg, Daniel Rothenstein, Nitsan Halevy, Jacob M. Rowe
Journal: Blood (2022)
Analysis of Immunological and Clinical Response to Vaccination Against Sars-COV-2 in Patients with Chronic Myeloid Leukemia
Authors: Alejandro ZURDO Castronuño, Miriam Solera Sainero, Magdalena Corona, Monserrat Torres, Guiomar Casado-Fernandez, Fernando Ramos-García, Javier Garcia-Pérez, María Aranzazú Murciano-Antón, María Jesús Blanchard, Juan Marquet Palomanes, Fernando Martin Moro, Mayte Pérez-Olmeida, Javier López Jiménez, Maria Teresa Coiras, Sara Rodriguez-Mora, Valentín Garcia-Gutiérrez
Journal: Blood (2022)
Assessing Time to Diagnosis, End-Organ Damage and Treatment Response in Young Newly Diagnosed Multiple Myeloma Patients
Authors: Michelle A. Quan, Kwan-Keat Ang, Joseph M Tuscano, Mehrdad Abedi, Brian A. Jonas, Naseem S Esteghamat, Jeanna L Welborn, Paul R. Kaesberg, Aaron S Rosenberg
Journal: Blood (2022)
Characterization of Dynamic Niche Signaling Modules during Embryonic Hematopoietic Development Using Spatial Transcriptomics
Authors: Xinjian Mao, Ning Zhang, Kate Hall, Kaitlyn Petentler, Allison Scott, Seth Malloy, Fang Liu, Kevin Ferro, Jessica Bell, Erin Hamilton, Jeffrey Haug, Yongfu Wang, Hua Li, Anoja Perera, Jay Unruh, Brian Slaughter, Xi C He, Nancy Speck, Linheng Li
Journal: Blood (2022)
Autologous Peripheral Blood Stem Cell Mobilisation Techniques, Stem Cell Yields and Practice Variation-By-Country in Patients with Myeloma Undergoing First Autologous Stem Cell Transplants in EBMT Centres between 2012 and 2021
Authors: Patrick John Hayden, Dirk-Jan Eikema, Linda Koster, John A Snowden, Denis Caillot, Gwendolyn Van Gorkom, Laimonas Griskevicius, William Arcese, Charles Crawley, Maurizio Musso, Claude-Eric Bulabois, Alexander M Martin, Tanja Netelenbos, Andrew McDonald, Johan Maertens, Matteo Parma, Arpad Illes, Cecilia Isaksson, Claudia Sossa, Joanna Drozd-Sokolowska, Kavita Raj, Meral Beksac, Stefan Schönland, Donal P. McLornan, Ibrahim Yakoub-Agha
Journal: Blood (2022)
Characteristics and Outcomes of Adult Patients with T Prolymphocytic Leukemia: A Real World Study of the French Innovative Leukemia Group (FILO)
Authors: Kamel Laribi, Loic Ysebaert, Luca Inchiappa, Bruno Villemagne, Yann Guillermin, Jérôme Paillassa, Fatiha Merabet, Cécile Guénot, Alix Baugier de Materre, Charles Herbaux, Kristell Mahe, Marion Divoux, Caroline Algrin, Stephane Lepretre, Damien Roos Weil, Cécile Tomowiak, David Ghez, Stéphanie Poulain, Marion Loirat, Caroline Dartigeas, Lise Willems, Olivier Tournilhac, Marie C Bene
Journal: Blood (2022)
Experiences and Views of Leukemia Patients: A Global Survey
Authors: Zack Pemberton-Whiteley, Samantha Nier, Nick York, Deborah Baker, Michael Rynne, Nicole Schroeter, Denis Costello, Lidija Pecova, Esther Natalie Oliva, Tatiana I. Ionova, Sam Salek, Jennie Bradley
Journal: Blood (2022)
Causes and Risk Factors of Early and Late Non-Relapse Mortality after CD19 CAR T-Cell Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Lysa Study from the Descar-T Registry
Authors: Jean Lemoine, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Thomas Gastinne, Marie Thérèse Rubio, Xavier Leleu, Mohamad Mohty, René-Olivier Casasnovas, Magalie Joris, Cristina Castilla-LLorente, Corinne Haioun, Olivier Hermine, Michael Loschi, Sylvain Carras, Pierre Bories, Tom Fradon, Charles Herbaux, Pierre Sesques, Steven Le Gouill, Franck Morschhauser, Catherine Thieblemont, Roch Houot
Journal: Blood (2022)
Prevalence of Monoclonal Gammopathies Detected By Mass Spectrometry and Their Risk Factors Among Black Africans in South Africa
Authors: David J. Lee, Habib El-Khoury, Luca Bertamini, Jean-Baptiste Alberge, Maya I. Davis, Jacqueline Perry, Dhananjay Sakrikar, David Barnidge, Mark C. Perkins, Stephen Harding, Derek Troske, Audrey Pentz, Thulisile Hlubi, Natalie Smyth, Anna Cowan, Angela C. Tramontano, Gad Getz, Timothy R. Rebbeck, Maureen Joffe, Wenlong Carl Chen, Catherine R. Marinac, Irene Ghobrial
Journal: Blood (2022)
The Efficacy and Safety of Modified Melphalan and Busulfan-Based Conditioning Regimen for Allogeneic-HSCT in Refractory/Relapsed or Persistent MRD Positive AML Patients
Authors: Shulian Chen, Xiaoyu Zhang, Weihua Zhai, Yi He, Sizhou Feng, Mingzhe Han, Ting Niu, Yajing Xu, Guangxun Gao, Shengjin Fan, Zeping Zhou, Fang Zhou, Xi Rui, Li Liu, Wei Yang, Qifa Liu, Xi Zhang, Erlie Jiang
Journal: Blood (2022)
Inflammatory and Coagulation Biomarkers in Patients with Sars-COV2 Infection Receiving COVID-19 Convalescent Plasma: The Bergamo Registry
Authors: Marina Marchetti, Angela Maria Palladino, Carmen J Tartari, Laura Russo, Cinzia Giaccherini, Sara Gamba, Silvia Bolognini, Cristina Verzeroli, Chiara Ticozzi, Oana Cristina Cretu, Francesca Schieppati, Luca Barcella, Anna Falanga
Journal: Blood (2022)
Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with <i>TP53</i> Mutations
Authors: Steven R Hwang, Yucai Wang, Kari G Rabe, Rong He, Saad S. Kenderian, Eli Muchtar, Paul J. Hampel, Neil E. Kay, Timothy G. Call, Amber Koehler, Amy L Behnken, Jose F. Leis, Esteban Braggio, Min Shi, David S. Viswanatha, Daniel L. Van Dyke, Susan L. Slager, Sameer A. Parikh, Wei Ding
Journal: Blood (2022)
Prospective Multi-Center Phase I/II Trial of Lenalidomide and Dose-Adjusted EPOCH-R in MYC-Associated B-Cell Lymphomas
Authors: Kirk Cahill, James Godfrey, Chadi Nabhan, Theodore G. Karrison, Jessica Robertson, Justin Kline, Kenneth S. Cohen, Michael R. Bishop, Walter M. Stadler, Reem Karmali, Parameswaran Venugopal, Seo-Hyun Kim, Aaron P. Rapoport, Sonali M. Smith
Journal: Blood (2022)
Timing and Nature of Infections in Multiple Myeloma Patients Treated with Anti-BCMA CAR-T Cells
Authors: Guido Lancman, Margaret Shyu, Megan Metzger, Kian Parsa, Hearn J. Cho, Samir Parekh, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa Sanchez, Santiago Thibaud, Sundar Jagannath, Ajai Chari, Shambavi Richard
Journal: Blood (2022)
High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit Primary CNS Lymphoma Patients - a Multicenter Study By the Cooperative PCNSL Study Group (MARTA study)
Authors: Elisabeth Schorb, Lisa Isbell, Andrea Kerkhoff, Stephan Mathas, Friederike Braulke, Gerlinde Egerer, Alexander Roeth, Simon Christian Schliffke, Peter Borchmann, Uta Brunnberg, Frank P. Kroschinsky, Robert Möhle, Andreas Rank, Dominique Wellnitz, Benjamin Kasenda, Lisa Pospiech, Julia Wendler, Gabriele Ihorst, Florian Scherer, Martina Deckert, Elina Henkes, Justus Duyster, Jürgen Finke, Gerald Illerhaus
Journal: Blood (2022)
Real-World Experience of Asciminib: Factors Associated with Response
Authors: Andrew J. Innes, Chloe Hayden, Victoria Orovboni, David Rees, Simone Claudiani, Fiona Fernando, Afzal Khan, Jennifer Byrne, Paolo Gallipoli, Sebastian Francis, Mhairi Copland, Gillian Horne, Manoj Raghavan, Claire Arnold, Angela Collins, Tanya Cranfield, Nicholas Cunningham, Akila Danga, Peter Forsyth, Rebecca Frewin, Paula Garland, Guy Hannah, Sandra Hassan, Brian James Patrick Huntly, Jissan Husain, Sudhakaran Makkuni, Kate Rothwell, Letizia Foroni, Jane F. Apperley, Dragana Milojkovic
Journal: Blood (2022)
Fried's Frailty Phenotype Predicts Mortality and Survival for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Authors: Cristian C. Taborda, Shannon H Gier, Avery W Stivale, Alexander E. Perl, Saar Gill, Daria V. Babushok, Elizabeth O. Hexner, Noelle V. Frey, Catherine Lai, Ximena Jordan Bruno, Mary Ellen Martin, Ivan Maillard, David L. Porter, Alison W. Loren, Keith W. Pratz, Selina M. Luger, Phyllis A. Gimotty, Shannon R. McCurdy
Journal: Blood (2022)
Results from Outreach: A Phase 2 Study of Lisocabtagene Maraleucel (Liso-cel) Administered As Outpatient (Outpt) or Inpatient (Inpt) Treatment in the Community/Nonuniversity Setting in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Authors: Yuliya Linhares, Cesar Freytes, Mohamad Cherry, Carlos Bachier, Michael Maris, Daanish Hoda, Juan Carlos Varela, Courtney Bellomo, Scott Cross, James Essell, Suzanne Fanning, Howard Terebelo, Habte Yimer, Jay Courtright, Jeff P. Sharman, Min Vedal, Connor Mailley, Ricardo Espinola, Bassam Mattar
Journal: Blood (2022)
Targeting the Methionine-MAT2A-SAM Axis of Acute Myeloid Leukemia with a Combination of Venetoclax and 8-Chloro-Adenosine or 8-Amino-Adenosine
Authors: Jiamin Guo, Ralf Buettner, Li Du, Yanzhong Yang, Zhenlong Li, Steve T Rosen
Journal: Blood (2022)
Rethinking the Gold Standard: Real-World Performance of the Serotonin Release Assay (SRA) and PF4-Dependent P-Selectin Expression Assay (PEA) in the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)
Authors: Jackson Hoesley, Rance C Siniard, Laura J. Taylor, Cari Reed, Marisa B. Marques, Jori E. May
Journal: Blood (2022)
Treatment Free Remission after Combination Therapy with Asciminib (ABL001) Plus Imatinib in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed after a Prior Attempt at TKI Discontinuation-H Jean Khoury Cure CML Consortium Study
Authors: Michael Mauro, Alexis Visotcky, Kathryn E Flynn, Jerald P. Radich, Jay Yang, Vivian G. Oehler, Jorge E. Cortes, Vamsi K Kota, Srinivas K. Tantravahi, Arielle Baim, Mei-Jie Zhang, Alexander Hinman, Ehab L. Atallah, Kendra Sweet
Journal: Blood (2022)
Senti-202, a Selective, Off-the-Shelf, Preclinical CAR-NK Cell Therapy with CD33 and/or FLT3 Activating CAR, Healthy Cell Protection from Endomucin (EMCN) Inhibitory CAR and Calibrated Release IL-15 for Hematologic Malignancies Including AML
Authors: Brian Garrison, Han Deng, Gozde Yucel, Nicholas W. Frankel, Russell Gordley, Michelle Hung, Derrick Lee, Marcus Gainer, Assen Roguev, Wesley Gorman, Nelia Leemans, Alice Lam, Yongshuai Li, Wilson Wong, Kanya L. Rajangam, Philip Lee, Tim Lu
Journal: Blood (2022)
Outcomes with Immunochemotherapy Plus Radiation Versus Immunochemotherapy Alone in Stage I Diffuse Large B-Cell Lymphoma: A Retrospective Study
Authors: Wern Lynn Ng, Allison M. Bock, Iuliia Kovalenko, Yijin Wert, Lay She Ng, Yucai Wang, Grzegorz S. Nowakowski
Journal: Blood (2022)
A Multicenter Prospective Study for Validation of the Korean Simple Geriatric Assessment Tool in Elderly Patients with Multiple Myeloma
Authors: Ji Yun Lee, Soo-Mee Bang, Sang-A Kim, Youngil Koh, Ho-Young Yhim, Lee Gyeong-Won, Chang-Ki Min, Young Rok Do, Hyo Jung Kim, Sung Hwa Bae, Hyeon-Seok Eom, Je-Jung Lee, Hyunkyung Park, Seung-Hyun Nam, Ji Hyun Lee, Sung-Hyun Kim, Hyun Jung Lee, Min Kyoung Kim
Journal: Blood (2022)
Universal Premedication for Pegylated (PEG)-Asparaginase Treatment in Children with Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LLy) Has No Impact on Frequency of Hypersensitivity Reactions
Authors: Andres Felipe Fajardo, Stephanie Cox, Paula MacDonald, Sabrina Millson, Uma H. Athale
Journal: Blood (2022)
Prolonged Survival in Bi-Allelic <i>TP53</i>-Mutated (<i>TP53</i>mut) MDS Subjects Treated with Oral Decitabine/Cedazuridine in the Ascertain Trial (ASTX727-02)
Authors: Michael R. Savona, James K McCloskey, Elizabeth A. Griffiths, Karen Yee, Amer M. Zeidan, Aref Al-Kali, Joachim Deeg, Prapti Patel, Mitchell Sabloff, Mary-Margaret Keating, Kim-Hien Dao, Nancy Zhu, Nashat Y. Gabrail, Salman Fazal, Joseph J. Maly, Olatoyosi Odenike, Hagop Kantarjian, Amy E. DeZern, Casey L. O'Connell, Gail J. Roboz, Lambert Busque, Rena Buckstein, Harshad Amin, Jasleen K. Randhawa, Brian Leber, Aram Oganesian, Winny Chan, Yong Hao, Mohammad Azab, Guillermo Garcia-Manero
Journal: Blood (2022)
The Impact of Chimeric Antigen Receptor T Cell Quality to Clinical Safety and Efficacy in Non-Hodgkin Lymphomas
Authors: Qian Wang, Liqing Kang, Yishan Duan, Mao Jin, Ying Zhu, Mengya Cong, Xin Xiang, Xiao Ma, Lei Yu, Depei Wu, Haiwen Huang
Journal: Blood (2022)
Hyper N-Glycosylated SEL1L3 As B-Cell Receptor Autoantigen of Primary Vitreoretinal Lymphoma
Authors: Moritz Bewarder, Michelle Elbert, Konstantinos Christofyllakis, Kristina Heyne, Gabi Carbon, Natalie Fadle, Evi Regitz, Maximilian Kiefer, Igor Age Kos, Joerg Thomas Bittenbring, Frank Neumann, Falko Fend, Irina Bonzheim, Lorenz Thurner
Journal: Blood (2022)
Multiple Myeloma Patients Aged 40 Years and Younger Have the Same Prognosis As Older Patients in an Analysis of Real-World Evidence from Latin America: A Study of 1,316 Patients from the Gelamm Latin American Multiple Myeloma Studygroup
Authors: Humberto Martinez-Cordero, Camila Peña, Natalia Paola Schutz, Virginia Bove, Fiorella Villano, Rocío Osorio, Mauricio Chandia, Cecilia Beltrán, Javier Schulz, Daniela Cardemil, Carolina Contreras, Carmen Gloria Vergara, Javiera Donoso, Marcela Espinoza, Gabriel La Rocca, Hernán López-Vidal, Pilar León, Macarena Roa, Christine Rojas, Pablo Soto, Sandra Aranda, Vivianne Torres, Paola Ochoa, Patricio Duarte, Guillermina Remaggi, Sebastian Yantorno, Ariel Corzo, Soledad Zabaljauregui, Claudia Shanley, Sergio Lopresti, Sergio Orlando, Veronica Verri, Luis Darío Quiroga, Juan Jose Garcia, Vanesa Fernandez, Dorotea Fantl, Jhoanna Ramirez, Alicia Molina, Pilar Papilco, Alex Mite, Ines Reyes, Brenner Sabando Vélez, Francisca M. Ramirez Aspiazu, Claudia Lucia Sossa, Virginia Abello, Henry Idrobo, Domingo Saavedra, Guillermo Quintero, Lina Gaviria, Rigoberto Gomez, Monica Osuna Pérez, Alicia Henao-Uribe, Luz del Carmen Tarín Arzaga, Omar Cantú-Martínez, David Gomez-Almaguer, Yarely Itzayana García-Navarrete, Antonio Cruz-Mora, Yahveth Cantero-Fortiz, Guillermo J. Ruiz-Arguelles, Eloisa Riva, Isabella Novoa-Caicedo
Journal: Blood (2022)
Subcutaneous Isatuximab Administration By an on-Body Delivery System (OBDS) in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Phase 1b Expansion Study Results
Authors: Hang Quach, Gurdeep Parmar, Enrique M. Ocio, H. Miles Prince, Albert Oriol, Nobuhiro Tsukada, Kazutaka Sunami, Pierre Bories, Sumit Madan, Dorothee Semiond, Disa Yu, Sandrine Macé, Florence Suzan, Philippe Moreau
Journal: Blood (2022)
CRC-403: A Phase 1/2 Study of bbT369, a Dual CD79a and CD20 Targeting CAR T Cell Drug Product with a Gene Edit, in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)
Authors: Frederick L. Locke, David B. Miklos, Michael Tees, Tina Bees, Aojun Li, Anna Truppel-Hartmann, Ian W. Flinn
Journal: Blood (2022)
Fatigue, Neuropathy, Psychological Distress and Their Association with Health-Related Quality of Life in Survivors of Diffuse Large B-Cell Lymphoma: A Prospective Cohort Study and Comparison with a Normative Population
Authors: Suzanne Neppelenbroek, Afke Ekels, Marie Jose Kersten, Flora Van Leeuwen, Djamila E. Issa, Noortje Thielen, Lonneke van de Poll-Franse, Simone Oerlemans
Journal: Blood (2022)
Characteristics and Clinical Outcomes in Patients (Pts) With Polycythemia Vera (PV) Receiving Ruxolitinib (RUX) After Hydroxyurea (HU): A Longitudinal Analysis From REVEAL
Authors: Aaron T. Gerds, Michael R. Grunwald, Stephen T. Oh, Evan Braunstein, Zhenyi Xue, Valkal Bhatt, Jingbo Yu, Ruben Mesa
Journal: Blood (2022)
Thrombocytopenia and Low CD4/CD8 Ratio at Apheresis Along with Prior Bendamustine Use Increase Risk of CAR-T Cell Manufacturing Failure
Authors: Tomoyasu Jo, Yasuyuki Arai, Satoshi Yoshihara, Minoru Kojima, Junko Ikemoto, Tomoe Uemura, Keita Iwaki, Noboru Yonetani, Shin-ichiro Fujiwara, Masaki Ri, Kaoru Kahata, Tokiko Nagamura-Inoue, Minami Yamada-Fujiwara, Ryuji Tanosaki
Journal: Blood (2022)
Outcomes of Patients with B-ALL with Concomitant BCR::ABL1 and CRLF2 Rearrangements
Authors: Emmanuel Almanza Huante, Elias Jabbour, Marina Konopleva, Cesar Nunez, Sergej Konoplev, Nicholas Short, Naveen Pemmaraju, Fatima Zahra Jelloul, Guilin Tang, Hagop Kantarjian, Nitin Jain
Journal: Blood (2022)
Validation of Angioimmunoblastic T-Cell Lymphoma (AITL) Score in Korean AITL Patients
Authors: Bohyun Moon, Hyungwoo Cho, Changhoon Yoo, Hyung-Don Kim, Shin Kim, Jin Sook Ryu, Jooryung Huh, Chan-Sik Park, Sang-wook Lee, Yoon Sei Lee, Cheolwon Suh
Journal: Blood (2022)
Impact of BCL2/MYC Protein Dual Expression and Other Clinical Factors on the Risk of Central Nervous System Progression in Patients with Primary Breast Diffuse Large B-Cell Lymphoma
Authors: Ho-Young Yhim, Dok-Hyun Yoon, Kyu Yun Jang, Deok-Hwan Yang, Sang Eun Yoon, Jin Seok Kim, Jeong-Ok Lee, Hyeon-Seok Eom, Kyoung Ha Kim, Ka-Won Kang, Young Rok Do, Soon Il Lee, Hyo Jung Kim, Ae Ri Ahn, Ga-Young Song, Han Sang Lee, Hyewon Lee, Seok Jin Kim, Won Seog Kim, Cheolwon Suh, Jae-Yong Kwak
Journal: Blood (2022)
Discordant Cellular and Humoral Responses to a 3-Dose COVID-19 mRNA Vaccination Schedule in Patients with Hematologic Malignancies
Authors: Cilia R. Pothast, Quincy Hofsink, Sabine Haggenburg, Bhoekhan S. Michel, Nienke J.E. Haverkate, Romy C. Dijkland, Kayleigh Van Dijk, Frederik J.H. Falkenburg, Annoek E.C. Broers, Jaap van Doesum, Robert S. Van Binnendijk, Gerco Den Hartog, Judith A. Burger, Joey H. Bouhuijs, Birgit I. Lissenberg-Witte, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sonja Zweegman, Arnon P. Kater, Kaz Groen, Tom van Meerten, Pim G.N.J. Mutsaers, Tim Beaumont, Marit J. Van Gils, Abraham Goorhuis, Mette D. Hazenberg, Inger S. Nijhof, Mirjam H.M. Heemskerk, Caroline E. Rutten
Journal: Blood (2022)
Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients : A Single Center Analysis of 97 Patients
Authors: Afnan Al-Sabbagh, Hazza Alzahrani, Majed J. Dasouki, Taimoor Hussain, Ayodele Alaiya, Ali Alahmari, Emad Ghabashi, Raghad Al Ammari, Abdullah Faruk Demirkaya, Moheeb Alawwami, Naeem A. Chaudhri, Fahad Alsharif, Walid Rasheed, Amr Hanbali, Marwan Shaheen, Feras Abdulaziz Alfraih, Riad Elfakih, Shahrukh K. Hashmi, Saud Alhayli, Ahmad S. Alotaibi, Alfadel Alshaibani, Abdulwahab Albabtain, Shaykhah Alotaibi, Mostafa Saleh, Ahmed Abdrabou, Ahmed Bin salman, Haroon Alfadhil, Ahmed Al Sagheir, Riad Youniss, Manju Abraham, Bandar Alotaibi, Sahar Ramadan, Ahmad Alhuraiji, Almohareb Fahad, Mahmoud Aljurf, Syed O. Ahmed
Journal: Blood (2022)
Double Donor Lymphocytes Infusion Reduced the Rejection in Tαβ Cell Depleted Hematopoietic Stem Cell Transplantation from Haploidentical Donors for Thalassemia Patients
Authors: Jianyun Liao, Chaoke Bu, Lan He, Yuelin He, Jujian He, Dan Chen, Bo Lyu, Weiwei Zhang, Haoran Tang, Xinrui Liu, Chunfu Li
Journal: Blood (2022)
Time-Limited Maintenance with Ibrutinib after First-Line Therapy and the Incremental Impact on Minimal Residual Disease (MRD) for Patients with Chronic Lymphocytic Leukemia (CLL)
Authors: Sikander Ailawadhi, Ricardo D Parrondo, Aneel Paulus, Betsy Laplant, Victoria R. Alegria, Ashley Zimmerman, Dustin Chapin, Taimur Sher, Vivek Roy, Asher Chanan-Khan
Journal: Blood (2022)
Functional Anti-Apoptotic Protein Dependence and Its Relation to Genomic Prognostic Markers and Response to Treatment in Chronic Lymphocytic Leukemia
Authors: Stephen Jun Fei Chong, Junyan Lu, Rebecca Valentin, Timothy Z. Lehmberg, Mary C Collins, Charles Herbaux, Carsten Utoft Niemann, Wolfgang Huber, Thorsten Zenz, Matthew S. Davids
Journal: Blood (2022)
Treatment Patterns and Outcomes of Patients with <i>NPM1</i>+ Acute Myeloid Leukemia (AML) Enrolled in the CONNECT® Myeloid Disease Registry
Authors: Daniel A. Pollyea, Jaroslaw P. Maciejewski, Gail J. Roboz, Karen Seiter, Bart L. Scott, Irene S. DeGutis, Pavel Kiselev, Edward Yu, Ali McBride, Willem Heydendael, Harry P. Erba
Journal: Blood (2022)
Pre-Transplant Assessment of Adult Sickle Cell Patients Shows a High Prevalence of Psychosocial Frailties before Allogeneic Stem Cell Transplant
Authors: Karen Sweiss, Santosh L. Saraf, Alison Doane, Monika Mandava, Ryan Sun, Mahir Khan, Zacharie Paul Charles Hamilton, Jaleel G. Sweis, Victor R. Gordeuk, Damiano Rondelli, Lisa Sharp, Pritesh Patel
Journal: Blood (2022)
Analysis of Clinical Characteristics and High-Risk Factors of Patients with Extramedullary Relapse Multiple Myeloma
Authors: XiaoYan Yue, GaoFeng Zheng, Donghua He, Yang Yang, Xiaoyan Han, Yi LI, Yi Zhao, Qingxiao Chen, WenJun Wu, He Huang, Zhen Cai, Jingsong He
Journal: Blood (2022)
Phase II Trial of Elotuzumab with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM) in the Post-Daratumumab Progression Setting
Authors: Sikander Ailawadhi, Ricardo D Parrondo, Betsy Laplant, Victoria R. Alegria, Jamie B Elliott, Taimur Sher, Aneel Paulus, Dustin Chapin, Keisha Heslop, Asher Chanan-Khan, Vivek Roy
Journal: Blood (2022)
Treatment Preferences of Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States, United Kingdom, France, Spain, Italy, and Germany: Results from a Discrete Choice Experiment
Authors: Rakesh Popat, Sikander Ailawadhi, David Kleinman, Sue Perera, Boris Gorsh, Caitlin Thomas, Sarah Mulnick, Alicia O'Neill, Melissa Ross, Prani Paka, Maya Hanna, Alexa Molinari, Shivaranjani Naine, Heather Gelhorn
Journal: Blood (2022)
Elranatamab in Combination with Daratumumab for Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 3 Magnetismm-5 Study Safety Lead-in Cohort
Authors: Sebastian Grosicki, Ulf-Henrik Mellqvist, Łukasz Pruchniewski, Jacob Crafoord, Suzanne Trudel, Chang-Ki Min, Darrell White, Adrian Alegre, Markus Hansson, Takashi Ikeda, Kazutaka Sunami, Eric Leip, Arthur Kudla, Gregory Finn, Youngil Koh
Journal: Blood (2022)